by TractManager | Feb 20, 2024 | Emerging Technology Report
Resamirigene bilparvovec is an investigational single-infusion gene therapy proposed for the treatment of X-linked myotubular myopathy.
by TractManager | Feb 20, 2024 | Emerging Technology Report
Human Acellular Vessel (HAV; Humacyte Inc.) is an investigational bioengineered vascular conduit proposed to establish arteriovenous access for hemodialysis in patients with end-stage renal disease.
by TractManager | Feb 15, 2024 | Emerging Technology Report
Human Acellular Vessel (HAV; formerly Humacyl) (Humacyte Inc.) is an off-the-shelf bioengineered vascular conduit proposed for urgent arterial repair following extremity vascular trauma when a synthetic graft is not indicated, and when autologous vein use is not...
by TractManager | Feb 14, 2024 | Emerging Technology Report
COMS One (Piomic Medical AG) is a concurrent optical and magnetic stimulation device for use as an adjunct to standard wound care to aid in the healing of chronic diabetic foot ulcers.
by TractManager | Feb 9, 2024 | Emerging Technology Report
The VenoValve is a porcine bioprosthetic venous valve under investigation for permanent implantation into the femoral vein for the treatment of deep vein reflux in chronic venous insufficiency.
Recent Comments